What is Epcoritamab: Uses, Dosage, Side Effects and More

Epcoritamab is a targeted cancer medication that helps your immune system fight certain types of blood cancers. It's a newer treatment option that works differently from traditional chemotherapy by training your body's own defense system to attack cancer cells more effectively.

This medication belongs to a group called bispecific antibodies, which act like a bridge connecting your immune cells to cancer cells. Think of it as giving your immune system better directions to find and destroy the cancer that's been hiding in your body.

What is Epcoritamab Used For?

Epcoritamab is specifically designed to treat adults with certain types of lymphoma, particularly diffuse large B-cell lymphoma (DLBCL). Your doctor may recommend this treatment if you've already tried other cancer treatments that haven't worked well enough or if your cancer has returned after previous treatments.

This medication is typically reserved for situations where other standard treatments haven't been successful. It's what doctors call a "salvage therapy" – meaning it's used to rescue patients when first-line treatments haven't achieved the desired results.

The drug targets a specific protein called CD20 that's found on the surface of certain cancer cells. By focusing on this target, epcoritamab can be more precise in attacking cancer while potentially causing fewer side effects than broader treatments.

How Does Epcoritamab Work?

Epcoritamab works by connecting two different types of cells in your body – your T-cells (immune system fighters) and the cancer cells. It's like creating a direct phone line between your immune system and the cancer so they can communicate more effectively.

Once this connection is made, your T-cells become much better at recognizing and destroying the cancer cells. The medication essentially teaches your immune system to see the cancer as a clear threat that needs to be eliminated.

This approach is considered a moderately strong treatment option. It's not as harsh as high-dose chemotherapy, but it's more intensive than some oral medications. Your body's immune response will become more active, which is why monitoring is so important during treatment.

How Should I Take Epcoritamab?

Epcoritamab is given as an injection under your skin (subcutaneous injection), similar to how insulin is given to people with diabetes. You won't take this medication at home – it's always administered by healthcare professionals in a clinic or hospital setting.

Before each injection, you'll receive pre-medications to help prevent certain side effects. These might include steroids, antihistamines, and fever reducers. Your healthcare team will give you these about 30 minutes to an hour before your epcoritamab injection.

You don't need to worry about taking this medication with food or on an empty stomach since it's not taken by mouth. However, it's important to stay well-hydrated before and after your treatment sessions.

The injection itself is typically given in your thigh, upper arm, or abdomen. Your healthcare provider will rotate the injection sites to prevent irritation. The actual injection takes just a few minutes, but you'll need to stay for monitoring afterward.

How Long Should I Take Epcoritamab For?

The duration of epcoritamab treatment varies significantly from person to person, depending on how well your cancer responds and how you tolerate the medication. Most people receive treatment for several months, but some may need it for a year or longer.

Your treatment typically starts with more frequent doses – often weekly for the first few cycles. If you're responding well and tolerating the medication, your doctor may space out the doses to every two or three weeks later in your treatment course.

Your healthcare team will regularly monitor your progress through blood tests, imaging scans, and physical examinations. These check-ups help determine whether the treatment is working and if it's safe to continue.

The decision to stop treatment depends on several factors: whether your cancer is responding, if you're experiencing manageable side effects, and your overall health status. Your doctor will work closely with you to find the right balance.

What Are the Side Effects of Epcoritamab?

Like all cancer treatments, epcoritamab can cause side effects, though not everyone experiences them the same way. The most common side effects are generally manageable with proper medical support and monitoring.

Here are the side effects you're most likely to encounter during treatment:

• Fatigue and feeling more tired than usual
• Injection site reactions like redness, swelling, or mild pain
• Fever and chills, especially after the first few doses
• Nausea and decreased appetite
• Headaches and muscle aches
• Diarrhea or constipation
• Skin rash or dry skin

These common side effects are usually mild to moderate and tend to improve as your body adjusts to the treatment. Your healthcare team has effective ways to manage most of these symptoms.

Some more serious side effects can occur, though they're less common. These require immediate medical attention and careful monitoring:

• Cytokine release syndrome (CRS) – a condition where your immune system becomes overactive, causing high fever, low blood pressure, and difficulty breathing
• Neurological problems like confusion, seizures, or difficulty speaking
• Severe infections due to lowered immune system function
• Significant drops in blood cell counts
• Liver problems indicated by yellowing of skin or eyes

Your medical team will monitor you closely for these more serious effects, especially during your first few treatments when they're most likely to occur.

There are also some rare but potentially serious side effects that occur in a small percentage of patients. These include severe allergic reactions, heart rhythm problems, and kidney dysfunction. While uncommon, your healthcare providers are trained to recognize and manage these complications quickly if they develop.

Who Should Not Take Epcoritamab?

Epcoritamab isn't suitable for everyone, and your doctor will carefully evaluate whether it's the right choice for your specific situation. Certain medical conditions or circumstances make this treatment inadvisable or require special precautions.

You should not receive epcoritamab if you have a known severe allergy to the medication or any of its components. Your doctor will review your allergy history thoroughly before starting treatment.

People with active, serious infections should typically wait until the infection is under control before beginning epcoritamab. Since this medication affects your immune system, fighting an existing infection while starting treatment can be dangerous.

Pregnant women should not receive epcoritamab as it can harm the developing baby. If you're able to become pregnant, you'll need to use effective birth control during treatment and for several months afterward.

Certain other conditions require careful consideration and may affect whether epcoritamab is right for you:

• History of serious heart problems or irregular heartbeat
• Severe liver or kidney disease
• Active autoimmune disorders
• Recent major surgery or radiation therapy
• History of severe neurological problems

Your healthcare team will weigh these factors against the potential benefits of treatment to make the best decision for your individual situation.

Epcoritamab Brand Names

The brand name for epcoritamab is Epkinly. This is the name you'll see on your medical records and treatment schedule when you receive this medication.

Epkinly is manufactured by Genmab and AbbVie, and it's the only currently available form of epcoritamab. Since it's a newer medication, there aren't yet any generic versions available.

When discussing your treatment with healthcare providers or insurance companies, you might hear both names used – epcoritamab (the generic name) and Epkinly (the brand name). They refer to the same medication.

Epcoritamab Alternatives

If epcoritamab isn't suitable for you or doesn't work as hoped, there are other treatment options available for lymphoma. Your doctor will consider your specific type of cancer, previous treatments, and overall health when exploring alternatives.

Other targeted therapies for lymphoma include CAR-T cell therapy, which involves removing your own immune cells, modifying them in a laboratory, and returning them to your body to fight cancer more effectively. This is a more complex treatment that requires hospitalization.

Traditional chemotherapy combinations remain important options for many people with lymphoma. These might include regimens like R-CHOP or other combinations that have been used successfully for many years.

Newer immunotherapy drugs like checkpoint inhibitors or other monoclonal antibodies might also be considered. The choice depends on your cancer's specific characteristics and your body's previous responses to treatment.

Your oncologist will work with you to determine the best next steps if epcoritamab isn't the right fit for your situation.

Is Epcoritamab Better Than Rituximab?

Epcoritamab and rituximab work differently and are typically used in different situations, so comparing them directly isn't straightforward. Both target CD20 proteins on cancer cells, but they use different mechanisms to fight the cancer.

Rituximab is an older, well-established treatment that's often used as part of first-line therapy for many types of lymphoma. It's usually given along with chemotherapy and has a long track record of safety and effectiveness.

Epcoritamab is newer and typically reserved for situations where other treatments, including rituximab-based regimens, haven't worked adequately. It's designed to be more potent by directly engaging your T-cells in the fight against cancer.

In clinical trials, epcoritamab has shown promise for people whose cancers have become resistant to rituximab-containing treatments. However, it also tends to cause more intensive side effects due to its stronger immune system activation.

Your doctor will choose between these treatments based on your specific situation, including whether you've had previous treatments and how your cancer has responded to them.